Company Filing History:
Years Active: 2016
Title: Innovations of Hui Bing in Pharmaceutical Science
Introduction
Hui Bing is a notable inventor based in Haikou, China. He has made significant contributions to the field of pharmaceutical science, particularly through his innovative work on conotoxin peptides. His research focuses on the development of novel therapeutic agents that can address various medical conditions.
Latest Patents
Hui Bing holds a patent for a novel α-conotoxin peptide, which includes a pharmaceutical composition and its various uses. This invention provides a unique approach to blocking acetylcholine receptors, which are crucial in treating conditions such as neuralgia, addiction, Parkinson's disease, dementia, schizophrenia, and certain cancers. The α-conotoxin peptide can be utilized in the manufacture of medications aimed at analgesia, smoking cessation, and drug withdrawal, as well as for treating mental diseases and cancers.
Career Highlights
Hui Bing is affiliated with Hainan University, where he conducts his research and development activities. His work has garnered attention for its potential impact on neuroscience and pharmacology. He has successfully translated his research into practical applications that can benefit patients suffering from various ailments.
Collaborations
Hui Bing collaborates with esteemed colleagues such as Sulan Luo and Dongting Zhangsun. Their combined expertise enhances the research efforts and contributes to the advancement of innovative solutions in the pharmaceutical field.
Conclusion
Hui Bing's contributions to pharmaceutical science through his innovative α-conotoxin peptide patent exemplify the potential of research in addressing complex medical challenges. His work continues to pave the way for new therapeutic options that can improve patient outcomes.